Specifically, in this trial umbilical cord blood is used to reduce the occurrence of Graft-Versus-Host Disease in patients receiving haploidentical HSCT transplants to treat Beta Thalassemia Major. Beta Thalassemia Major is a genetic blood disorder that involves the decreased production of normal adult hemoglobin.
http://ift.tt/1opVFFx
http://ift.tt/1opVFFx
No comments:
Post a Comment